| Literature DB >> 36199360 |
Shijie Guo1, Pengyu Wang2, Ping Song2, Ning Li1.
Abstract
Being the first barrier between the human body and external environments, our skin is highly vulnerable to injuries. As one of the conventional therapies, botanicals prepared in different topical formulations have been applied as medical care for centuries. With the current increase of clinical requirements, applications of botanicals are heading towards nanotechnologies, typically fused with electrospinning that forms nanofibrous membranes suitable for skin wound healing. In this review, we first introduced the main process of wound healing, and then presented botanicals integrated into electrospun matrices as either loaded drugs, or carriers, or membrane coatings. In addition, by addressing functional features of individual botanicals in the healing of injured skin, we further discussed the bioactivity of botanical electrospun membranes in relevant to the medical issues solved in the process of wound healing. As achieved by pioneer studies, due to infrequent adverse effects and the diversity in resources of natural plants, the development of electrospun products based on botanicals is gaining greater attention. However, investigations in this field have mainly focused on different methodologies used in the preparation of nanofibrous membranes containing botanicals, their translation into clinical practices remains unaddressed. Accordingly, we propose that potential clinical applications of botanical electrospun membranes require not only the further expansion and understanding of botanicals, but also an establishment of standard criteria for the evaluation of wound healing and evolutions of technologies to support the large-scale manufacturing industry.Entities:
Keywords: botanical; electrospinning; nanofiber; wound dressing; wound healing
Year: 2022 PMID: 36199360 PMCID: PMC9527302 DOI: 10.3389/fbioe.2022.1006129
Source DB: PubMed Journal: Front Bioeng Biotechnol ISSN: 2296-4185
FIGURE 1Electrospinning of botanicals for skin wound healing. A variety of botanicals can be electrospun as wound dressings in the form of loaded drugs, or carriers, or coatings, to provide a suitable microenvironment for different stages of wound healing, including hemostasis, inflammation, proliferation and remodeling.
Botanicals as loaded-drugs used in electrospinning for wound healing.
| Bioactive agent | Polymers | Electrospinning design | Hydrophilicity | Drug release (%) | Tensile properties (MPa) | Diameter (nm) | Properties for wound healing | References | |
|---|---|---|---|---|---|---|---|---|---|
| Water contact angles (°) | Swelling index (%) | ||||||||
| anemoside B4 | chitosan/polyvinyl alcohol | blend | 31.1 (1 s) | N/A | 70–80 (10 h) | N/A | 150–250 | 1. Anti-inflammation |
|
| 2. Antioxidation | |||||||||
| 3. Proliferation: re-epithelization/collagen matrix deposition/angiogenesis | |||||||||
| 4. Prominent water absorption | |||||||||
| 5. Biomimetic elastic mechanical properties | |||||||||
| 6. Sustained release of anemoside B4 | |||||||||
| dihydroquercetin | chitosan/polyvinylpyrrolidone | Blend | 10.847 (2 s) | N/A | N/A | N/A | 532 ± 75 | 1. Antibacteria: |
|
| 2. Antioxidation | |||||||||
| 3. Proliferation: re-epithelization/angiogenesis | |||||||||
| 4. Favorable morphology | |||||||||
| 5. Thermal stability | |||||||||
| 6. Hydrophilicity | |||||||||
| epigallocatechin-3-O-gallate | poly (L-Lactic-co-caprolactone)/gelatin | coaxial | 53 | N/A | about 36 (12 h) 86 (72 h) | 4.5 | 295 | 1. Hemostasis |
|
| 2. Antibacteria: | |||||||||
| 3. Antioxidation | |||||||||
| 4. Excellent biocompatibility | |||||||||
| 5. Hydrophilicity | |||||||||
| asiaticoside | polyvinyl alcohol/sodium alginate/silk fibroin | blend/crosslinked (glutaraldehyde) | N/A | 100 (480 min) | 60–80 (24 h) | 20.65 ± 1.79 | 100–140 | 1. Antibacteria: |
|
| 2. Proliferation: re-epithelization/collagen matrix deposition | |||||||||
| 3. Permeability | |||||||||
| 4. Sustained release of asiaticoside | |||||||||
| 5. Wettability | |||||||||
| 6. Extendibility | |||||||||
| emodin | polyvinylpyrrolidone/cellulose acetate | Coaxial core-shell | N/A | N/A | 85.55 ± 0.67 (12 h) | N/A | 692 ± 93 (shell) 223 ± 31 (core) | 1. Antibacteria: methicillin-resistant |
|
| 2. Sustained release of emodin | |||||||||
| 3. No cytotoxicity | |||||||||
| sesamols | cellulose acetate/zein | blend | 36.5 (5 s) | N/A | Ethanol: about 70 (20 min)/90 (120 min) Water: 70 (24 h) | N/A | 150–250 | 1. Anti-inflammation |
|
| 2. Proliferation: angiogenesis | |||||||||
| 3. Small diameter | |||||||||
| 4. Uniform distribution | |||||||||
| 5. Stable intermolecular structure | |||||||||
| 6. Low infiltration speed | |||||||||
| 7. High stability in water | |||||||||
| astragulus polysaccharide | poly (lactide-co-glycolide) | blend | N/A | N/A | N/A | N/A | 570 ± 120 | 1. Proliferation: angiogenesis |
|
| 2. High drug-loading capacity | |||||||||
| 3. Long lasting pharmacological effects | |||||||||
| baicalein | silk fibroin/polyvinylpyrrolidone | blend | N/A | N/A | silk fibroin/baicalein: about 30 (24 h) silk fibroin/polyvinylpyrrolidone/baicalein: about 65 (24 h)v | N/A | 267 ± 40 | 1. Antibacteria: |
|
| 2. Anti-inflammatory | |||||||||
| 3. Proliferation: angiogenesis/synthesis of collagen fibers | |||||||||
| 4. Sustained release of baicalein | |||||||||
| thymol | silk fibroin/polycaprolactone/hyaluronic acid | blend/crosslinked (dried under vacuum at room temperature)/multi-layer | 103.10 ± 6.57 (top layer) 38.77 ± 5.32 (bottom layer) | 42 (PBS, pH = 8) | 91.87 ± 0.99 (PBS, pH = 8) | 7.59 ± 1.26 | 471.4 ± 151.6 (top layer) 295.4 ± 88.4 (bottom layer) | 1. Antibacteria: |
|
| 2. Antioxidation | |||||||||
| 3. Proliferation: fibroblast adhesion and proliferation | |||||||||
| 4. Permeability | |||||||||
| 5. Biocompatibility | |||||||||
| 6. Wettability | |||||||||
| 7. Extendibility | |||||||||
| quercetin | poly (lactic acid)/graphene oxide | blend | N/A | N/A | 89.96 (300 min) 87.69 (1 min/50 Hz) | 1.661 ± 1.469 | 1,100 ± 210 | 1. Faster quercetin released |
|
| 2. Electro-responsive drug delivery system | |||||||||
| 3. Biocompatibility | |||||||||
| 4. Anti-inflammation | |||||||||
| 5. Proliferation: fibroblast adhesion | |||||||||
| curcumin | chitosan/gelatin/polycaprolactone/polyethylene oxide/silk fibroin | blend/three layers | 95.6 (10 s/s layer) | 450–500 | about 40 (pH = 6.8/24 h) | N/A | 556 ± 82 (second layer) | 1. Suitable water absorption capacity and water vapor transmission rate |
|
| 3. Hemostasis | |||||||||
| 4. Antibacteria: | |||||||||
| 5. Antioxidation | |||||||||
| 6. Anti-inflammation | |||||||||
| 7. Proliferation: epidermal regeneration/collagen deposition | |||||||||
| Chamomile extract | polycaprolactone/carboxyethyl chitosan/polyvinyl alcohol | blend/crosslinked -glutaraldehyde/three layers | 136.1 ± 3.1 (first layer) 41.8 ± 1.0 (third layer) | N/A | 65 (5 h) 18 (336 h) | 9.1 ± 1.01 (third layer) | 248 ± 30 (first layer) 149 ± 33 (third layer) | 1. Antibacteria: |
|
| 2. Antioxidation | |||||||||
| 3. Favorable morphology | |||||||||
| 4. Extendibility | |||||||||
| 5. Sustained drug release | |||||||||
|
| Polyvinylpyrrolidone | blend (hand-held electrospinner) | 5.35 | N/A | N/A | N/A | 1710 ± 820 | 1. Antibacteria: |
|
| 2. Easiness in operation | |||||||||
|
| gelatin/polyvinyl alcohol | blend/crosslinked (glutaraldehyde) | 44 ± 4 | N/A | N/A | N/A | 150–350 | 1. Antibacteria: |
|
| 2. Proliferation: fibroblast proliferation/synthesis of collagen fibers | |||||||||
| 3. Hydrophilicity | |||||||||
| 4. Biodegradability | |||||||||
|
| gelatin (core) polycaprolactone/gelatin (shell) | coaxial/core-shell | 40.3 ± 5.1 (USE/minocycline hydrochloride) 38.3 ± 4.5 (CME/minocycline hydrochloride) | N/A | 50 (USE/minocycline hydrochloride): 3.3 days 50 (CME/minocycline hydrochloride): 2.1 days | 4.3 ± 1.1 (USE/minocycline hydrochloride) 3.5 ± 1 (CME/minocycline hydrochloride) | 302 ± 44 (USE/minocycline hydrochloride) 340 ± 64 (CME/minocycline hydrochloride) | 1. Antibacteria: methicillin-resistant |
|
| 2. Proliferation: re-epithelization/collagen matrix deposition | |||||||||
| 3. Favorable morphology | |||||||||
| 4. Wettability | |||||||||
| 5. Enhanced mechanical properties | |||||||||
| 6. Drug synergy | |||||||||
| 7. Sustained drug release | |||||||||
|
|
| Blend | N/A | N/A | about 60 (10 h) | N/A | 520.7 ± 196 | 1. Antibacteria: |
|
| 2. Sustained drug release | |||||||||
| 3. Stable drug structure | |||||||||
|
| polyvinyl alcohol/chitosan | blend/two layers (cotton bandage gauze & polyvinyl alcohol/ | 42.37 ± 7.52 (polyvinyl alcohol/ | 400 (pH = 5.5) 320 (pH = 8.0) | 72.18 ± 3.71 (pH = 5.5/6 h) 62.68 ± 3.87 (pH = 8.0/6 h) | 26.55 ± 1.41 | 208.11 ± 57.92 (polyvinyl alcohol/ | 1. Antibacteria: |
|
| 2. Biocompatibility | |||||||||
| 3. Wettability | |||||||||
Drug release assays were performed by default in PBS (pH = 7).
All specimens (50 mm × 10 mm, n = 5) were tested with a crosshead speed of 10 mm min−1 until breakage.
The ends of the samples were attached to the tensile testing machine’s gripping units, and a load of 10 kN was applied at a rate of 1 mm/min until the samples broke.
Thymol is added to the silk fibroin and hyaluronic acid of the bottom layer.
Curcumin was incorporated into polycaprolactone as the second layer.
Chamomile extract was added to the second and third layers.
GSylvestre leaves were extracted by ultrasonic-assisted extraction and cold immersion extraction to obtain two extracts, abbreviated as USE, and CME, respectively.
Botanicals as carriers in electrospinning for wound healing.
| Botanicals | Bioactive agent | Electrospinning design | Properties for wound healing | Advantages of botanicals | References |
|---|---|---|---|---|---|
| Lignin | - | Nanospider (needleless electrospinning) | 1. Skin-friendly | 1. Easy to access |
|
| 2. Acting on the modulation of matrix metalloproteinases, cytokines, and human beta-defensin 2 | 2. Biodegradability | ||||
| 3. Reducing the dependence on fossil fuel resources | |||||
| Guar gum | Paramagnetic iron oxide Fe3O4 nanoparticles | Blend/fibers obtained from alkaline stock solutions | 1. Enhanced nanoparticle homogeneity | 1. Hydrophilic |
|
| 2. Increased nanoparticle stability | 2. Non-toxic | ||||
| 3. Adequate levels of cytotoxicity and cell adhesion/proliferation | 3. Biocompatible | ||||
| 4. Abundantly available in nature | |||||
| 5. Keeping long-term iron oxide nanoparticle stabilization through steric repulsion reducing both aggregation and sedimentation | |||||
| 6. The ability to chelate metal ions in alkaline pH | |||||
| Arabic gum/karaya gum/kondagogu gum | - | Nanospider/methane plasma treatment | 1. Improved water contact angle | 1. Non-toxic |
|
| 2. High surface porosity and roughness | 2. Hydrophilic | ||||
| 3. Superior hydrophobic properties | 3. Acid stability | ||||
| 4. High viscosity | |||||
| 5. Potential antibacterial agent | |||||
| 6. Stabilizer and reducing agent in the synthesis of metal/metal oxide nanoparticles | |||||
| 7. Environmentally friendly | |||||
| Mucilage of | - | Blend/crosslinked (glutaraldehyde) | 1. Faster epithelization | 1. Anti-bacteria: Gram-positive and Gram-negative bacteria |
|
| 2. Hemocompatibility | 2. Anti-oxidation | ||||
| 3. Biodegradability | 3. Optimal skin moisturizing effect | ||||
| Pectin | - | Co-blended with polyethylene oxide, followed by selective washing off polyethylene oxide (containing only 1.5% polyethylene oxide) | A high Young’s modulus: 358.5 MPa | 1. Anti-inflammation |
|
| 2. Combination of ion-crosslinkable property | |||||
| 3. Biocompatible | |||||
| 4. Biodegradable | |||||
| 5. Hydrophilic |